Edo Great Iruoghene, Mafe Alice Njolke, Ali Ali B M, Yousif Emad, Makia Raghda S, Isoje Endurance Fegor, Igbuku Ufuoma Augustina, Akpoghelie Patrick Othuke, Owheruo Joseph Oghenewogaga, Opiti Rapheal Ajiri, Essaghah Arthur Efeoghene Athan, Ahmed Dina S, Umar Huzaifa
Department of Chemistry, Faculty of Science, Delta State University of Science and Technology, Ozoro, Delta State, Nigeria.
Department of Chemistry, College of Sciences, Al-Nahrain University, Baghdad, Iraq.
J Microencapsul. 2025 Jul 23:1-25. doi: 10.1080/02652048.2025.2531776.
Probiotic microencapsulation is an advanced technique designed to protect live probiotic microorganisms by enclosing them within a protective matrix, typically composed of biocompatible biopolymers.
This review provides a comprehensive analysis of recent advancements in bio-polymer coatings for probiotic microencapsulation, with a focus on chitosan and its synergistic combinations with other materials.
This methods highlights the necessity for continued innovation in bio-polymer coatings, emphasizing the development of bio-responsive materials, AI-driven formulation strategies, and next-generation encapsulation technologies to meet the evolving demands of functional foods and precision therapeutics.
Probiotic microencapsulation plays a critical role in protecting probiotics from environmental stresses, improving stability, and ensuring targeted delivery. Innovations in chitosan-based encapsulation, including its combination with bio-polymers such as alginate, gelatin, and pectin, have enhanced encapsulation efficiency, controlled release, and probiotic viability. Cutting-edge techniques such as nanotechnology, stimuli-responsive coatings, and hybrid bio-polymers are explored for their potential to optimize probiotic performance in food and pharmaceutical applications.
Despite these advancements, obstacles remain in ensuring consistent release profiles, mitigating the inhibitory effects of chitosan on certain probiotic strains, and optimizing large-scale production while maintaining cost-effectiveness. The need for personalized probiotic therapies has driven research into adaptive encapsulation systems tailored to individual gut microbiota compositions.
益生菌微胶囊化是一种先进技术,旨在通过将活的益生菌微生物包裹在保护性基质中来保护它们,该基质通常由生物相容性生物聚合物组成。
本综述全面分析了用于益生菌微胶囊化的生物聚合物涂层的最新进展,重点关注壳聚糖及其与其他材料的协同组合。
本方法强调了生物聚合物涂层持续创新的必要性,强调了生物响应材料、人工智能驱动的配方策略和下一代封装技术的发展,以满足功能性食品和精准治疗不断变化的需求。
益生菌微胶囊化在保护益生菌免受环境压力、提高稳定性和确保靶向递送方面起着关键作用。基于壳聚糖的封装创新,包括其与藻酸盐、明胶和果胶等生物聚合物的组合,提高了封装效率、控释和益生菌活力。探索了纳米技术、刺激响应涂层和混合生物聚合物等前沿技术在优化益生菌在食品和制药应用中的性能方面的潜力。
尽管取得了这些进展,但在确保一致的释放曲线、减轻壳聚糖对某些益生菌菌株的抑制作用以及在保持成本效益的同时优化大规模生产方面仍然存在障碍。对个性化益生菌疗法的需求推动了针对个体肠道微生物群组成的适应性封装系统的研究。